Multicell Techs Stock Today
PerformanceFair
| Odds Of DistressSmall
|
Multicell Techs has about a 33 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of November 2025 and ending today, the 17th of February 2026. Click here to learn more.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. The company has 5 B outstanding shares. More on Multicell Techs
Multicell Techs cannot be verified against its exchange. Apparently, Multicell Techs is not available for investing at the moment. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshMulticell Pink Sheet Highlights
| Chairman | Gerald Newmin |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Multicell Techs [MCET] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Multicell Techs's market, we take the total number of its shares issued and multiply it by Multicell Techs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Multicell Techs conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5 B outstanding shares.
Multicell Techs currently holds about 281.12 K in cash with (1.09 M) of positive cash flow from operations.
Check Multicell Techs Probability Of Bankruptcy
Multicell Stock Against Markets
Multicell Pink Sheet Analysis Notes
The company had not issued any dividends in recent years. Multicell Techs had 1:5 split on the 20th of May 2005. MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island. Multicell Techs operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for Multicell Techs is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Multicell Techs contact Gerald Newmin at 401-762-0045 or learn more at www.multicelltech.com.Multicell Techs Investment Alerts
| Multicell Techs is way too risky over 90 days horizon | |
| Multicell Techs has some characteristics of a very speculative penny stock | |
| Multicell Techs appears to be risky and price may revert if volatility continues | |
| Multicell Techs currently holds 36.43 K in liabilities. Multicell Techs has a current ratio of 0.19, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Multicell Techs until it has trouble settling it off, either with new capital or with free cash flow. So, Multicell Techs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Multicell Techs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Multicell to invest in growth at high rates of return. When we think about Multicell Techs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 49.32 K. Net Loss for the year was (380.07 K) with profit before overhead, payroll, taxes, and interest of 49.32 K. | |
| Multicell Techs currently holds about 281.12 K in cash with (1.09 M) of positive cash flow from operations. |
Multicell Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Multicell Techs's market, we take the total number of its shares issued and multiply it by Multicell Techs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Multicell Profitablity
The company has Profit Margin (PM) of (0.31) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Multicell Techs, as well as the relationship between them.Multicell Techs Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Multicell Techs Tanh Of Price Series is a hyperbolic price transformation function.
Multicell Techs Outstanding Bonds
Multicell Techs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Multicell Techs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Multicell bonds can be classified according to their maturity, which is the date when Multicell Techs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in Multicell Techs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.